A Novel TP53 Tandem Duplication in a Child with Li-Fraumeni Syndrome
Open Access
- 1 March 2022
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Molecular Case Studies
- Vol. 8 (3)
- https://doi.org/10.1101/mcs.a006181
Abstract
Li-Fraumeni syndrome (LFS) is one of the most common cancer predisposition syndromes that affects both children and adults. Individuals with LFS are at an increased risk of developing various types of cancer over their lifetime including soft tissue sarcomas, osteosarcomas, breast cancer, leukemia, brain tumors, and adrenocortical carcinoma. Heterozygous germline pathogenic variants in the tumor suppressor gene TP53 are the known causal genetic defect for LFS. Single nucleotide variants (SNVs) including missense substitutions that occur in the highly conserved DNA binding domain of the protein are the most common alterations, followed by nonsense and splice site variants. Gross copy number changes in TP53 are rare and account for less than 1% of all variants. Using next-generation sequencing (NGS) panels, we identified a paternally inherited germline intragenic duplication of TP53 in a child with metastatic osteosarcoma who later developed acute myeloid leukemia (AML). Transcriptome sequencing (RNA-Seq) demonstrated the duplication was tandem, encompassing exons 2-6 and 28 nucleotides of the untranslated region (UTR) upstream of the start codon in exon 2. The inclusion of the 28 nucleotides is expected to result in a frameshift with a stop codon 18 codons downstream of the exon 6, leading to a loss-of-function allele. This case highlights the significance of simultaneous identification of both significant copy number variants as well as SNVs/indels using NGS panels.Keywords
This publication has 16 references indexed in Scilit:
- Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumoursEuropean Journal of Human Genetics, 2013
- TP53p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patientBMC Cancer, 2013
- Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeBMC Cancer, 2013
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- MTML-msBayes: Approximate Bayesian comparative phylogeographic inference from multiple taxa and multiple loci with rate heterogeneityBMC Bioinformatics, 2011
- TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypesJournal of Medical Genetics, 2010
- Identification of a novel duplication in the APC gene using multiple ligation probe amplification in a patient with familial adenomatous polyposisCancer Genetics and Cytogenetics, 2008
- The Nonsense-Mediated Decay RNA Surveillance PathwayAnnual Review of Biochemistry, 2007
- Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.2003
- GermlineTP53 mutations and Li-Fraumeni syndromeHuman Mutation, 2003